New Enterprise Associates

New Enterprise Associates is a prominent American venture capital firm, founded in 1977 and headquartered in Chevy Chase, Maryland. With over four decades of activity, it has established itself as one of the largest and most enduring firms in the venture capital industry, managing multiple funds that invest across stages from seed to growth. The firm is known for its deep involvement in the technology and healthcare sectors, having backed numerous companies that have become leaders in their fields.

History

The firm was established in 1977 by Frank Bonsal Jr., Chuck Newhall, and Dick Kramlich, with its early roots deeply connected to the burgeoning technology scene around the San Francisco Bay Area and the East Coast of the United States. Its formation coincided with a pivotal era for the venture capital industry, following the landmark reduction of the capital gains tax in the United States. Throughout the 1980s and 1990s, it played a significant role in financing the first wave of personal computer and enterprise software companies, expanding its presence with offices in Menlo Park, California and New York City. A major milestone came in 1999 when it closed its ninth fund, NEA IX, at over one billion dollars, cementing its status as a major institutional investor. The firm has continued to raise successive funds, adapting its strategy through various economic cycles including the dot-com bubble and the financial crisis of 2007–2008.

Investment focus

The firm maintains a dual-sector investment strategy, concentrating its capital and expertise primarily on technology and healthcare. Within technology, its interests span cloud computing, artificial intelligence, enterprise software, fintech, and consumer internet businesses. In healthcare, its focus includes biotechnology, medical devices, and healthcare services, investing in companies from early-stage research through commercial growth. It employs a stage-agnostic approach, making investments ranging from seed and Series A financing to later-stage growth equity rounds in both private and public companies. This strategy is supported by a large, sector-specialized team of investors and operating partners who provide portfolio companies with strategic guidance.

Notable investments

Over its history, the firm has been an early or major investor in a vast array of successful companies that have defined their industries. In technology, its portfolio has included seminal companies such as Salesforce, Workday, Tableau Software, Databricks, and MongoDB. Its healthcare investments have supported groundbreaking firms like Genentech, a pioneer in biotechnology, along with Immunogen, 3Com, and UroGen Pharma. Many of these companies have achieved significant public offerings or been acquired by larger industry players, generating substantial returns. The firm's continued activity is evident in its backing of newer enterprises like Robinhood and Cloudflare.

Leadership and team

The firm has been led by a succession of notable partners who have shaped the venture capital landscape. Founding partners Dick Kramlich and Chuck Newhall were instrumental in its early growth, while Scott Sandell currently serves as its Chairman and has been a driving force behind its technology investments. Other key leaders have included Peter J. Barris and Forest Baskett. The partnership comprises experienced investors with backgrounds as entrepreneurs, engineers, and scientists from institutions like Stanford University and MIT, as well as former executives from companies such as Microsoft and Google. This team operates from its main offices in Chevy Chase, Maryland, Menlo Park, California, and New York City, with a global perspective on innovation.

Impact and recognition

The firm is widely regarded as one of the most influential and successful venture capital firms in history, having raised over twenty billion dollars in committed capital since its inception. Its long-term track record has consistently placed it at the top of industry rankings by publications like Forbes and PitchBook. Beyond financial returns, its impact is measured by the foundational role its portfolio companies have played in shaping modern industries, from cloud infrastructure to biopharmaceuticals. The firm and its partners are frequently recognized on lists such as the Forbes Midas List, and its alumni have gone on to found or lead other significant investment firms and technology companies, extending its influence across the global innovation ecosystem. Category:Venture capital firms of the United States Category:Companies based in Montgomery County, Maryland Category:Financial companies established in 1977